- 現金殖利率: 0.48%、總殖利率: 0.48%、5年平均現金配發率: 112.75%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 0.08 | -91.75 | 0.28 | -68.89 | 0.00 | 0 | 350.00 | 277.22 | 0.00 | 0 | 350.00 | 277.22 |
| 2024 (4) | 0.97 | 0 | 0.90 | 28.57 | 0.00 | 0 | 92.78 | 0 | 0.00 | 0 | 92.78 | 0 |
| 2023 (3) | -0.13 | 0 | 0.70 | -72.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 0.36 | 20.0 | 140.0 | 0.10 | -37.5 | -33.33 | 0.36 | 350.0 | 140.0 |
| 25Q4 (7) | 0.30 | 372.73 | 20.0 | 0.16 | 164.0 | 900.0 | 0.08 | 136.36 | -91.84 |
| 25Q3 (6) | -0.11 | 59.26 | -650.0 | -0.25 | -169.44 | -457.14 | -0.22 | -83.33 | -129.73 |
| 25Q2 (5) | -0.27 | -280.0 | -196.43 | 0.36 | 140.0 | 63.64 | -0.12 | -180.0 | -116.9 |
| 25Q1 (4) | 0.15 | -40.0 | 0.0 | 0.15 | 850.0 | 0.0 | 0.15 | -84.69 | 0.0 |
| 24Q4 (3) | 0.25 | 1150.0 | 0.0 | -0.02 | -128.57 | 0.0 | 0.98 | 32.43 | 0.0 |
| 24Q3 (2) | 0.02 | -92.86 | 0.0 | 0.07 | -68.18 | 0.0 | 0.74 | 4.23 | 0.0 |
| 24Q2 (1) | 0.28 | 0.0 | 0.0 | 0.22 | 0.0 | 0.0 | 0.71 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 2.2 | 17.61 | 13.64 | 7.67 | 3.15 | 5.76 | N/A | - | ||
| 2026/3 | 1.87 | 10.73 | -4.49 | 5.47 | -0.54 | 5.47 | 0.96 | - | ||
| 2026/2 | 1.69 | -11.37 | -3.82 | 3.6 | 1.63 | 5.61 | 0.93 | - | ||
| 2026/1 | 1.91 | -5.62 | 7.02 | 1.91 | 7.02 | 5.78 | 0.9 | - | ||
| 2025/12 | 2.02 | 8.64 | 17.23 | 22.31 | 2.36 | 5.7 | 0.86 | - | ||
| 2025/11 | 1.86 | 1.88 | 2.92 | 20.29 | 1.08 | 5.66 | 0.87 | - | ||
| 2025/10 | 1.82 | -7.78 | 4.29 | 18.43 | 0.9 | 5.56 | 0.88 | - | ||
| 2025/9 | 1.98 | 12.43 | 7.08 | 16.61 | 0.54 | 5.53 | 0.82 | - | ||
| 2025/8 | 1.76 | -1.94 | -5.88 | 14.63 | -0.28 | 5.34 | 0.84 | - | ||
| 2025/7 | 1.79 | 0.48 | -7.5 | 12.87 | 0.53 | 5.44 | 0.83 | - | ||
| 2025/6 | 1.79 | -3.71 | -2.18 | 11.07 | 1.97 | 5.58 | 0.79 | - | ||
| 2025/5 | 1.86 | -4.17 | -1.52 | 9.29 | 2.81 | 5.75 | 0.76 | - | ||
| 2025/4 | 1.94 | -1.16 | 4.85 | 7.43 | 3.95 | 5.65 | 0.78 | - | ||
| 2025/3 | 1.96 | 11.51 | 8.68 | 5.5 | 3.64 | 5.5 | 0.7 | - | ||
| 2025/2 | 1.76 | -1.37 | 9.16 | 3.54 | 1.05 | 5.26 | 0.73 | - | ||
| 2025/1 | 1.78 | 3.37 | -5.84 | 1.78 | -5.84 | 5.31 | 0.72 | - | ||
| 2024/12 | 1.72 | -4.62 | 5.17 | 21.8 | 2.08 | 5.28 | 0.75 | - | ||
| 2024/11 | 1.81 | 3.23 | 0.46 | 20.07 | 1.83 | 5.4 | 0.73 | - | ||
| 2024/10 | 1.75 | -5.32 | -6.93 | 18.27 | 1.96 | 5.47 | 0.72 | - | ||
| 2024/9 | 1.85 | -1.17 | -6.24 | 16.52 | 3.01 | 5.66 | 0.68 | - | ||
| 2024/8 | 1.87 | -3.62 | 0.85 | 14.67 | 4.3 | 5.64 | 0.68 | - | ||
| 2024/7 | 1.94 | 6.25 | 9.73 | 12.8 | 4.83 | 5.65 | 0.68 | - | ||
| 2024/6 | 1.83 | -3.06 | 3.75 | 10.86 | 4.0 | 5.56 | 0.72 | - | ||
| 2024/5 | 1.88 | 2.03 | 4.65 | 9.03 | 4.05 | 5.53 | 0.73 | - | ||
| 2024/4 | 1.85 | 2.45 | 7.43 | 7.15 | 3.89 | 5.26 | 0.76 | - | ||
| 2024/3 | 1.8 | 12.01 | -6.48 | 5.3 | 2.71 | 5.3 | N/A | - | ||
| 2024/2 | 1.61 | -14.94 | 3.06 | 3.5 | 8.19 | 5.14 | N/A | - | ||
| 2024/1 | 1.89 | 15.48 | 12.97 | 1.89 | 12.97 | 5.33 | N/A | - | ||
| 2023/12 | 1.64 | -8.89 | -22.59 | 21.35 | -36.42 | 5.32 | N/A | - | ||
| 2023/11 | 1.8 | -4.36 | -14.36 | 19.71 | -37.35 | 5.65 | N/A | - | ||
| 2023/10 | 1.88 | -4.62 | -5.11 | 17.91 | -38.99 | 5.7 | N/A | - | ||
| 2023/9 | 1.97 | 6.3 | 1.73 | 16.03 | -41.44 | 5.59 | N/A | - | ||
| 2023/8 | 1.85 | 4.85 | -14.71 | 14.06 | -44.73 | 5.38 | N/A | - | ||
| 2023/7 | 1.77 | 0.46 | -46.31 | 12.21 | -47.53 | 5.33 | N/A | - | ||
| 2023/6 | 1.76 | -2.22 | -65.38 | 10.44 | -47.73 | 5.28 | N/A | 去年營收因子公司出售快篩試劑，致使本月營收較去年同期減少達50%以上 | ||
| 2023/5 | 1.8 | 4.74 | -65.09 | 8.68 | -41.71 | 5.45 | N/A | 去年營收因子公司出售快篩試劑，致使本月營收較去年同期減少達50%以上 | ||
| 2023/4 | 1.72 | -10.82 | -32.9 | 6.88 | -29.33 | 5.21 | N/A | - | ||
| 2023/3 | 1.93 | 23.44 | -22.56 | 5.16 | -28.05 | 5.16 | N/A | - | ||
| 2023/2 | 1.56 | -6.75 | -29.68 | 3.24 | -30.97 | 5.35 | N/A | - | ||
| 2023/1 | 1.67 | -20.87 | -32.13 | 1.67 | -32.13 | 5.89 | N/A | - | ||
| 2022/12 | 2.12 | 0.79 | -14.01 | 33.58 | 14.58 | 6.2 | N/A | - | ||
| 2022/11 | 2.1 | 5.96 | -19.84 | 31.46 | 17.2 | 6.02 | N/A | - | ||
| 2022/10 | 1.98 | 2.25 | -25.28 | 29.36 | 21.21 | 6.09 | N/A | - | ||
| 2022/9 | 1.94 | -10.88 | -30.92 | 27.38 | 26.92 | 7.4 | N/A | - | ||
| 2022/8 | 2.17 | -33.99 | -17.28 | 25.45 | 35.56 | 10.55 | N/A | - | ||
| 2022/7 | 3.29 | -35.22 | 20.12 | 23.27 | 44.17 | 13.53 | N/A | - | ||
| 2022/6 | 5.08 | -1.39 | 109.69 | 19.98 | 49.09 | 12.8 | N/A | 因嘉碩生醫出售快篩試劑，致使本月營收較去年同期增加達50%以上 | ||
| 2022/5 | 5.16 | 101.32 | 125.9 | 14.89 | 35.7 | 10.21 | N/A | 本月營收因子公司出售快篩試劑，致使本月營收較去年同期增加達50%以上 | ||
| 2022/4 | 2.56 | 2.92 | 11.5 | 9.74 | 12.02 | 7.27 | N/A | - | ||
| 2022/3 | 2.49 | 12.08 | 4.13 | 7.18 | 12.2 | 7.18 | N/A | - | ||
| 2022/2 | 2.22 | -10.0 | 24.43 | 4.69 | 17.02 | 7.15 | N/A | - | ||
| 2022/1 | 2.47 | 0.25 | 11.06 | 2.47 | 11.06 | 7.55 | N/A | - | ||
| 2021/12 | 2.46 | -6.04 | 23.37 | 29.31 | 37.18 | 7.73 | N/A | - | ||
| 2021/11 | 2.62 | -1.22 | 39.04 | 26.84 | 38.6 | 8.07 | N/A | - | ||
| 2021/10 | 2.65 | -5.46 | 50.07 | 24.23 | 38.56 | 8.08 | N/A | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/9 | 2.8 | 6.7 | 60.17 | 21.57 | 37.26 | 8.17 | N/A | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/8 | 2.63 | -4.13 | 62.3 | 18.77 | 34.39 | 7.79 | N/A | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/7 | 2.74 | 13.07 | 52.35 | 16.14 | 30.73 | 7.45 | N/A | 本月營收因出貨量增加及調整營運策略,致使本月營收較去年同期增加達50%以上。 | ||
| 2021/6 | 2.42 | 6.22 | 41.44 | 13.4 | 27.04 | 0.0 | N/A | - | ||
| 2021/5 | 2.28 | -0.63 | 29.17 | 10.98 | 24.24 | 0.0 | N/A | - |